10X Genomics
Serge Saxonov is the CEO and Co-Founder of 10X Genomics. Serge was previously with QuantaLife, where they were VP Applications and responsible for content, applications and diagnostics opportunities for ddPCR technology. Prior to that, Serge was with 23andMe as the First Employee, Founding Architect, and Director of R&D. At 23andMe, they were responsible for product conception, recruiting the early team, and building many key elements of the technology.
Serge Saxonov earned their PhD in Biomedical Informatics from Stanford University and their AB in Applied Math from Harvard University.
Ruth De Backer - Chief Business Officer, Eric Whitaker - Chief Legal Officer, and Ben Hindson - Chief Scientific Officer, President & Co-Founder report to Serge Saxonov.
This person is not in any offices
10X Genomics
18 followers
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend, and have been cited in over 3,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,200 issued patents and patent applications.